Skip to main content
OpenTrials

Clinical trial condition

Melanoma, Cutaneous Malignant

Explore clinical trials studying Melanoma, Cutaneous Malignant. Study availability and eligibility vary by location and protocol.

15 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Melanoma, Cutaneous Malignant trial results

Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

NCT06743126

Conditions
Melanoma, Melanoma, Cutaneous Malignant, Neoplasms, +10 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 66 locations
View Trial Details
Completed

A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors

NCT06208124

Conditions
Adenocarcinoma, Advanced Solid Tumor (Phase 1), Bronchial Neoplasms, +25 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome

NCT01748448

Conditions
Cutaneous Malignant Melanoma, Melanoma, Melanoma, Cutaneous Malignant, +11 more
Locations
  • Universitair Ziekenhuis Antwerpen, Dermatology Edegem, Belgium
  • UZLeuven Gasthuisberg Leuven, Belgium
  • Chef de Service du Service Universitaire de Dermatologie Liège, Belgium
  • Dep. of Dermatology, Medical and Health Science Center University of Debrecen Debrecen, Hungary
View Trial Details
Completed

Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma

NCT02308553

Conditions
Cutaneous Malignant Melanoma, Melanoma, Melanoma, Cutaneous Malignant, +11 more
Locations
  • University Hospital Essen Essen, North Rhine-Westphalia, Germany
  • Elbeklinikum Buxtehude Buxtehude, Germany
  • SRH Wald-Klinikum Gera Gera, Germany
  • National Centre for Tumour Diseases (NCT) Heidelberg, Germany
View Trial Details

Related conditions